Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
NAUT
NAUT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NAUT News
Nautilus (NAUT) Third Quarter 2025 Earnings Call Summary
Oct 28 2025
NASDAQ.COM
VTYX, MEDP, INBX Surge in After-Hours Trading Following Important Announcements
Oct 23 2025
NASDAQ.COM
Biotech Stocks Surge After Hours: Insider Purchases, Trial Progress, and Strategic Partnerships Drive Growth
Sep 11 2025
NASDAQ.COM
Biotech Stocks Surge in After-Hours Trading Following Trial News, Insider Purchases, and Conference Excitement
Sep 10 2025
NASDAQ.COM
Nautilus Biotechnology, Inc. (NAUT) Q2 2025 Earnings Conference Call Transcript
Aug 01 2025
Newsfilter
Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
May 27 2025
Newsfilter
Insider Purchase: CEO of $NAUT Buys 23,933 Shares
Mar 21 2025
NASDAQ.COM
TD Cowen Reaffirms Their Buy Rating on Nautilus Biotechnolgy (NAUT)
Feb 28 2025
Business Insider
Goldman Sachs Downgrades Nautilus Biotechnology to Sell, Lowers Price Target to $1.75
Dec 05 2024
Benzinga
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
Oct 31 2024
Globenewswire
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer
Sep 17 2024
Newsfilter
Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Aug 14 2024
Newsfilter
Jefferies Assumes Nautilus Biotechnology at Hold, Lowers Price Target of $3
Jun 03 2024
Benzinga
NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q1 2024
Apr 30 2024
Business Insider
Nautilus Biotechnology GAAP EPS of -$0.15 beats by $0.01
Apr 30 2024
earning
Notable earnings before Tuesday's open
Apr 29 2024
earning
Show More News
